Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MPW | Restricted common stock units | Award | $0 | +1.8M | $0.00 | 1.8M | Mar 8, 2024 | Common stock, par value $0.001 | 1.8M | $0.00 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | The restricted stock units were granted under the Medical Properties Trust, Inc. Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified increases in the price of the Company's common stock during the four-year period ending on December 31, 2027 (previously reported as March 8, 2028) as follows: (i) if the Company's share price increases to $7.00, 100% of the restricted stock units will be earned; (ii) if the Company's share price increases to $8.50, 200% of the restricted stock units will be earned; and (iii) if the Company's share price increases to $10.00, 300% of the restricted stock units will be earned. The actual number of restricted stock units to be earned will be determined based on the trailing 20-trading day average closing price of the Company's common stock (continued on footnote 2). |
F2 | Earned restricted stock units will be settled in cash in equal quarterly installments over one year (previously reported as two years) following the date the restricted stock units are earned, subject to the grantee's continued employment through such date, provided that all unsettled earned restricted stock units will be settled in cash in full on the date that the Compensation Committee makes the final determination regarding achievement of the performance metrics following the end of the four year performance period. Each restricted stock unit will be settled in cash based on the value of a share of common stock. |